Boston Scientific Corp.
(NYSE : BSX)

( )
BSX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.53%149.630.7%$1822.06m
MDTMedtronic Plc
0.62%111.730.6%$500.02m
TMOThermo Fisher Scientific, Inc.
0.08%317.351.0%$366.52m
ABTAbbott Laboratories
0.44%84.930.8%$361.79m
ISRGIntuitive Surgical, Inc.
-0.10%574.792.4%$316.75m
BDXBecton, Dickinson & Co.
1.50%261.111.1%$299.11m
EWEdwards Lifesciences Corp.
0.53%230.381.2%$287.40m
SYKStryker Corp.
-0.06%198.011.3%$258.78m
BSXBoston Scientific Corp.
-0.43%43.821.1%$250.38m
BAXBaxter International, Inc.
0.88%83.011.8%$206.13m
DXCMDexCom, Inc.
-1.47%212.368.3%$204.63m
PODDInsulet Corp.
1.12%180.196.7%$160.58m
MTDMettler-Toledo International, Inc.
1.16%762.935.4%$158.47m
ALGNAlign Technology, Inc.
0.58%275.236.4%$146.22m
HOLXHologic, Inc.
0.77%52.601.7%$145.35m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.